Figure 1. Top 20 biologic pathway GO terms enriched in TNFα-treated HRMECs. Biologic Pathway GO term enrichment in TNFα-treated HRMECs compared to vehicle-treated HRMECs was determined using DAVID. Terms were considered significant at p<0.05.